ALZHEIMER'S DISEASE PSYCHOSIS

Clinical trials for ALZHEIMER'S DISEASE PSYCHOSIS explained in plain language.

Never miss a new study

Get alerted when new ALZHEIMER'S DISEASE PSYCHOSIS trials appear

Sign up with your email to follow new studies for ALZHEIMER'S DISEASE PSYCHOSIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet finished but already full! 1

New hope for Alzheimer's psychosis: 52-Week safety trial launches

Symptom relief ENROLLING_BY_INVITATION

This study tests the long-term safety of an experimental drug, ACP-204, for people with Alzheimer's disease who also experience psychosis (hallucinations or delusions). It is an open-label extension, meaning everyone gets the drug, and follows 752 adults aged 55-95 for 52 weeks. …

Matched conditions: ALZHEIMER'S DISEASE PSYCHOSIS

Phase: PHASE3 • Sponsor: ACADIA Pharmaceuticals Inc. • Aim: Symptom relief

Last updated Apr 30, 2026 15:52 UTC

ALZHEIMER'S DISEASE PSYCHOSIS

Get alerted when new ALZHEIMER'S DISEASE PSYCHOSIS trials appear

New hope for Alzheimer's psychosis: 52-Week safety trial launches